Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:ivarimod'
(id=6885603 ; fe=en:ivarimod ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=4065 creation date=2017-06-25 touchdate=2025-07-25 10:34:06.000)
≈ 137 relations sortantes

  1. en:ivarimod -- r_associated #0: 43 / 1 -> en:hyperimmune bovine colostrum
    n1=en:ivarimod | n2=en:hyperimmune bovine colostrum | rel=r_associated | relid=0 | w=43
  2. en:ivarimod -- r_associated #0: 42 / 0.977 -> en:histamine-1 receptor antagonist
    n1=en:ivarimod | n2=en:histamine-1 receptor antagonist | rel=r_associated | relid=0 | w=42
  3. en:ivarimod -- r_associated #0: 39 / 0.907 -> en:h1299 tumor cell lysate vaccine
    n1=en:ivarimod | n2=en:h1299 tumor cell lysate vaccine | rel=r_associated | relid=0 | w=39
  4. en:ivarimod -- r_associated #0: 39 / 0.907 -> en:ponesimod
    n1=en:ivarimod | n2=en:ponesimod | rel=r_associated | relid=0 | w=39
  5. en:ivarimod -- r_associated #0: 38 / 0.884 -> en:cndo-109-activated allogeneic natural killer cells
    n1=en:ivarimod | n2=en:cndo-109-activated allogeneic natural killer cells | rel=r_associated | relid=0 | w=38
  6. en:ivarimod -- r_associated #0: 35 / 0.814 -> en:anti-cd20 monoclonal antibody-interferon-alpha fusion protein ign002
    n1=en:ivarimod | n2=en:anti-cd20 monoclonal antibody-interferon-alpha fusion protein ign002 | rel=r_associated | relid=0 | w=35
  7. en:ivarimod -- r_associated #0: 35 / 0.814 -> en:anti-pd-l1/tgfbetarii fusion protein msb0011359c
    n1=en:ivarimod | n2=en:anti-pd-l1/tgfbetarii fusion protein msb0011359c | rel=r_associated | relid=0 | w=35
  8. en:ivarimod -- r_associated #0: 35 / 0.814 -> en:immunotherapy regimen mkc-1106-mt
    n1=en:ivarimod | n2=en:immunotherapy regimen mkc-1106-mt | rel=r_associated | relid=0 | w=35
  9. en:ivarimod -- r_associated #0: 35 / 0.814 -> en:laquinimod sodium
    n1=en:ivarimod | n2=en:laquinimod sodium | rel=r_associated | relid=0 | w=35
  10. en:ivarimod -- r_associated #0: 35 / 0.814 -> en:multifunctional/multitargeted anticancer agent omn54
    n1=en:ivarimod | n2=en:multifunctional/multitargeted anticancer agent omn54 | rel=r_associated | relid=0 | w=35
  11. en:ivarimod -- r_associated #0: 35 / 0.814 -> en:rilonacept
    n1=en:ivarimod | n2=en:rilonacept | rel=r_associated | relid=0 | w=35
  12. en:ivarimod -- r_associated #0: 34 / 0.791 -> en:714-x
    n1=en:ivarimod | n2=en:714-x | rel=r_associated | relid=0 | w=34
  13. en:ivarimod -- r_associated #0: 34 / 0.791 -> en:almurtide
    n1=en:ivarimod | n2=en:almurtide | rel=r_associated | relid=0 | w=34
  14. en:ivarimod -- r_associated #0: 34 / 0.791 -> en:apilimod mesylate
    n1=en:ivarimod | n2=en:apilimod mesylate | rel=r_associated | relid=0 | w=34
  15. en:ivarimod -- r_associated #0: 34 / 0.791 -> en:brilacidin oral rinse
    n1=en:ivarimod | n2=en:brilacidin oral rinse | rel=r_associated | relid=0 | w=34
  16. en:ivarimod -- r_associated #0: 34 / 0.791 -> en:chining decoction
    n1=en:ivarimod | n2=en:chining decoction | rel=r_associated | relid=0 | w=34
  17. en:ivarimod -- r_associated #0: 34 / 0.791 -> en:cridanimod
    n1=en:ivarimod | n2=en:cridanimod | rel=r_associated | relid=0 | w=34
  18. en:ivarimod -- r_associated #0: 34 / 0.791 -> en:french maritime pine bark extract
    n1=en:ivarimod | n2=en:french maritime pine bark extract | rel=r_associated | relid=0 | w=34
  19. en:ivarimod -- r_associated #0: 34 / 0.791 -> en:immunoconjugate
    n1=en:ivarimod | n2=en:immunoconjugate | rel=r_associated | relid=0 | w=34
  20. en:ivarimod -- r_associated #0: 34 / 0.791 -> en:immunosuppressant
    n1=en:ivarimod | n2=en:immunosuppressant | rel=r_associated | relid=0 | w=34
  21. en:ivarimod -- r_associated #0: 34 / 0.791 -> en:nitroglycerin transdermal patch
    n1=en:ivarimod | n2=en:nitroglycerin transdermal patch | rel=r_associated | relid=0 | w=34
  22. en:ivarimod -- r_associated #0: 34 / 0.791 -> en:sheng-yu-tang
    n1=en:ivarimod | n2=en:sheng-yu-tang | rel=r_associated | relid=0 | w=34
  23. en:ivarimod -- r_associated #0: 34 / 0.791 -> en:superagonist interleukin-15:interleukin-15 receptor alphasu/fc fusion complex alt-803
    n1=en:ivarimod | n2=en:superagonist interleukin-15:interleukin-15 receptor alphasu/fc fusion complex alt-803 | rel=r_associated | relid=0 | w=34
  24. en:ivarimod -- r_associated #0: 34 / 0.791 -> en:ticolubant
    n1=en:ivarimod | n2=en:ticolubant | rel=r_associated | relid=0 | w=34
  25. en:ivarimod -- r_associated #0: 32 / 0.744 -> en:2-o, 3-o desulfated heparin
    n1=en:ivarimod | n2=en:2-o, 3-o desulfated heparin | rel=r_associated | relid=0 | w=32
  26. en:ivarimod -- r_associated #0: 32 / 0.744 -> en:atiprimod dimaleate
    n1=en:ivarimod | n2=en:atiprimod dimaleate | rel=r_associated | relid=0 | w=32
  27. en:ivarimod -- r_associated #0: 32 / 0.744 -> en:chemokine receptor antagonist
    n1=en:ivarimod | n2=en:chemokine receptor antagonist | rel=r_associated | relid=0 | w=32
  28. en:ivarimod -- r_associated #0: 32 / 0.744 -> en:edratide
    n1=en:ivarimod | n2=en:edratide | rel=r_associated | relid=0 | w=32
  29. en:ivarimod -- r_associated #0: 32 / 0.744 -> en:esonarimod
    n1=en:ivarimod | n2=en:esonarimod | rel=r_associated | relid=0 | w=32
  30. en:ivarimod -- r_associated #0: 32 / 0.744 -> en:fucosylated umbilical cord blood regulatory t cells
    n1=en:ivarimod | n2=en:fucosylated umbilical cord blood regulatory t cells | rel=r_associated | relid=0 | w=32
  31. en:ivarimod -- r_associated #0: 32 / 0.744 -> en:heterodimeric interleukin-15
    n1=en:ivarimod | n2=en:heterodimeric interleukin-15 | rel=r_associated | relid=0 | w=32
  32. en:ivarimod -- r_associated #0: 32 / 0.744 -> en:mannose-binding lectin
    n1=en:ivarimod | n2=en:mannose-binding lectin | rel=r_associated | relid=0 | w=32
  33. en:ivarimod -- r_associated #0: 32 / 0.744 -> en:omtriptolide sodium
    n1=en:ivarimod | n2=en:omtriptolide sodium | rel=r_associated | relid=0 | w=32
  34. en:ivarimod -- r_associated #0: 32 / 0.744 -> en:umbilical cord blood-derived natural killer cells
    n1=en:ivarimod | n2=en:umbilical cord blood-derived natural killer cells | rel=r_associated | relid=0 | w=32
  35. en:ivarimod -- r_associated #0: 31 / 0.721 -> en:allogeneic cd56-positive cd3-negative natural killer cells
    n1=en:ivarimod | n2=en:allogeneic cd56-positive cd3-negative natural killer cells | rel=r_associated | relid=0 | w=31
  36. en:ivarimod -- r_associated #0: 31 / 0.721 -> en:amnion-derived cellular cytokine solution
    n1=en:ivarimod | n2=en:amnion-derived cellular cytokine solution | rel=r_associated | relid=0 | w=31
  37. en:ivarimod -- r_associated #0: 31 / 0.721 -> en:atiprimod
    n1=en:ivarimod | n2=en:atiprimod | rel=r_associated | relid=0 | w=31
  38. en:ivarimod -- r_associated #0: 31 / 0.721 -> en:boswellia serrata extract
    n1=en:ivarimod | n2=en:boswellia serrata extract | rel=r_associated | relid=0 | w=31
  39. en:ivarimod -- r_associated #0: 31 / 0.721 -> en:clonidine-containing mucoadhesive buccal tablet
    n1=en:ivarimod | n2=en:clonidine-containing mucoadhesive buccal tablet | rel=r_associated | relid=0 | w=31
  40. en:ivarimod -- r_associated #0: 31 / 0.721 -> en:glatiramer acetate
    n1=en:ivarimod | n2=en:glatiramer acetate | rel=r_associated | relid=0 | w=31
  41. en:ivarimod -- r_associated #0: 31 / 0.721 -> en:hpv16 l2/e6/e7 fusion protein vaccine ta-cin
    n1=en:ivarimod | n2=en:hpv16 l2/e6/e7 fusion protein vaccine ta-cin | rel=r_associated | relid=0 | w=31
  42. en:ivarimod -- r_associated #0: 31 / 0.721 -> en:il-10 immunomodulator mk-1966
    n1=en:ivarimod | n2=en:il-10 immunomodulator mk-1966 | rel=r_associated | relid=0 | w=31
  43. en:ivarimod -- r_associated #0: 31 / 0.721 -> en:immunomodulator ohr/avr118
    n1=en:ivarimod | n2=en:immunomodulator ohr/avr118 | rel=r_associated | relid=0 | w=31
  44. en:ivarimod -- r_associated #0: 31 / 0.721 -> en:larazotide
    n1=en:ivarimod | n2=en:larazotide | rel=r_associated | relid=0 | w=31
  45. en:ivarimod -- r_associated #0: 31 / 0.721 -> en:lenalidomide
    n1=en:ivarimod | n2=en:lenalidomide | rel=r_associated | relid=0 | w=31
  46. en:ivarimod -- r_associated #0: 31 / 0.721 -> en:pimelautide
    n1=en:ivarimod | n2=en:pimelautide | rel=r_associated | relid=0 | w=31
  47. en:ivarimod -- r_associated #0: 31 / 0.721 -> en:recombinant cytokine
    n1=en:ivarimod | n2=en:recombinant cytokine | rel=r_associated | relid=0 | w=31
  48. en:ivarimod -- r_associated #0: 31 / 0.721 -> en:resiquimod
    n1=en:ivarimod | n2=en:resiquimod | rel=r_associated | relid=0 | w=31
  49. en:ivarimod -- r_associated #0: 30 / 0.698 -> en:allodepleted haploidentical t cells-expressing inducible caspase 9
    n1=en:ivarimod | n2=en:allodepleted haploidentical t cells-expressing inducible caspase 9 | rel=r_associated | relid=0 | w=30
  50. en:ivarimod -- r_associated #0: 30 / 0.698 -> en:anti-pd-1 fusion protein amp-224
    n1=en:ivarimod | n2=en:anti-pd-1 fusion protein amp-224 | rel=r_associated | relid=0 | w=30
  51. en:ivarimod -- r_associated #0: 30 / 0.698 -> en:autologous glioma cell lysate
    n1=en:ivarimod | n2=en:autologous glioma cell lysate | rel=r_associated | relid=0 | w=30
  52. en:ivarimod -- r_associated #0: 30 / 0.698 -> en:cathelicidin ll-37
    n1=en:ivarimod | n2=en:cathelicidin ll-37 | rel=r_associated | relid=0 | w=30
  53. en:ivarimod -- r_associated #0: 30 / 0.698 -> en:epetirimod
    n1=en:ivarimod | n2=en:epetirimod | rel=r_associated | relid=0 | w=30
  54. en:ivarimod -- r_associated #0: 30 / 0.698 -> en:glatiramer
    n1=en:ivarimod | n2=en:glatiramer | rel=r_associated | relid=0 | w=30
  55. en:ivarimod -- r_associated #0: 30 / 0.698 -> en:high-selenium baker's yeast
    n1=en:ivarimod | n2=en:high-selenium baker's yeast | rel=r_associated | relid=0 | w=30
  56. en:ivarimod -- r_associated #0: 30 / 0.698 -> en:imiquimod
    n1=en:ivarimod | n2=en:imiquimod | rel=r_associated | relid=0 | w=30
  57. en:ivarimod -- r_associated #0: 30 / 0.698 -> en:immunoadjuvant
    n1=en:ivarimod | n2=en:immunoadjuvant | rel=r_associated | relid=0 | w=30
  58. en:ivarimod -- r_associated #0: 30 / 0.698 -> en:lactobacillus brevis cd2 lozenge
    n1=en:ivarimod | n2=en:lactobacillus brevis cd2 lozenge | rel=r_associated | relid=0 | w=30
  59. en:ivarimod -- r_associated #0: 30 / 0.698 -> en:pd-l1/pd-l2/vista antagonist ca-170
    n1=en:ivarimod | n2=en:pd-l1/pd-l2/vista antagonist ca-170 | rel=r_associated | relid=0 | w=30
  60. en:ivarimod -- r_associated #0: 30 / 0.698 -> en:poly-gamma glutamic acid
    n1=en:ivarimod | n2=en:poly-gamma glutamic acid | rel=r_associated | relid=0 | w=30
  61. en:ivarimod -- r_associated #0: 29 / 0.674 -> en:adalimumab
    n1=en:ivarimod | n2=en:adalimumab | rel=r_associated | relid=0 | w=29
  62. en:ivarimod -- r_associated #0: 29 / 0.674 -> en:anti-il-4/il-13 combination agent qbx258
    n1=en:ivarimod | n2=en:anti-il-4/il-13 combination agent qbx258 | rel=r_associated | relid=0 | w=29
  63. en:ivarimod -- r_associated #0: 29 / 0.674 -> en:apilimod dimesylate capsule
    n1=en:ivarimod | n2=en:apilimod dimesylate capsule | rel=r_associated | relid=0 | w=29
  64. en:ivarimod -- r_associated #0: 29 / 0.674 -> en:atiprimod dihydrochloride
    n1=en:ivarimod | n2=en:atiprimod dihydrochloride | rel=r_associated | relid=0 | w=29
  65. en:ivarimod -- r_associated #0: 29 / 0.674 -> en:dimepranol acedoben
    n1=en:ivarimod | n2=en:dimepranol acedoben | rel=r_associated | relid=0 | w=29
  66. en:ivarimod -- r_associated #0: 29 / 0.674 -> en:fingolimod
    n1=en:ivarimod | n2=en:fingolimod | rel=r_associated | relid=0 | w=29
  67. en:ivarimod -- r_associated #0: 29 / 0.674 -> en:fingolimod hydrochloride
    n1=en:ivarimod | n2=en:fingolimod hydrochloride | rel=r_associated | relid=0 | w=29
  68. en:ivarimod -- r_associated #0: 29 / 0.674 -> en:highly purified staphylococcal protein a prtx-100
    n1=en:ivarimod | n2=en:highly purified staphylococcal protein a prtx-100 | rel=r_associated | relid=0 | w=29
  69. en:ivarimod -- r_associated #0: 29 / 0.674 -> en:iguratimod
    n1=en:ivarimod | n2=en:iguratimod | rel=r_associated | relid=0 | w=29
  70. en:ivarimod -- r_associated #0: 29 / 0.674 -> en:injectable astragalus membranaceus polysaccharide
    n1=en:ivarimod | n2=en:injectable astragalus membranaceus polysaccharide | rel=r_associated | relid=0 | w=29
  71. en:ivarimod -- r_associated #0: 29 / 0.674 -> en:isatoribine
    n1=en:ivarimod | n2=en:isatoribine | rel=r_associated | relid=0 | w=29
  72. en:ivarimod -- r_associated #0: 29 / 0.674 -> en:microparticle mdp/bacterial dna-containing mis416
    n1=en:ivarimod | n2=en:microparticle mdp/bacterial dna-containing mis416 | rel=r_associated | relid=0 | w=29
  73. en:ivarimod -- r_associated #0: 29 / 0.674 -> en:monoacetyldiglyceride ec-18
    n1=en:ivarimod | n2=en:monoacetyldiglyceride ec-18 | rel=r_associated | relid=0 | w=29
  74. en:ivarimod -- r_associated #0: 29 / 0.674 -> en:tabilautide
    n1=en:ivarimod | n2=en:tabilautide | rel=r_associated | relid=0 | w=29
  75. en:ivarimod -- r_associated #0: 28 / 0.651 -> en:agaricus blazei murill extract
    n1=en:ivarimod | n2=en:agaricus blazei murill extract | rel=r_associated | relid=0 | w=28
  76. en:ivarimod -- r_associated #0: 28 / 0.651 -> en:anti-cd40l fc-fusion protein bms-986004
    n1=en:ivarimod | n2=en:anti-cd40l fc-fusion protein bms-986004 | rel=r_associated | relid=0 | w=28
  77. en:ivarimod -- r_associated #0: 28 / 0.651 -> en:anti-pd-1 checkpoint inhibitor pf-06801591
    n1=en:ivarimod | n2=en:anti-pd-1 checkpoint inhibitor pf-06801591 | rel=r_associated | relid=0 | w=28
  78. en:ivarimod -- r_associated #0: 28 / 0.651 -> en:apilimod
    n1=en:ivarimod | n2=en:apilimod | rel=r_associated | relid=0 | w=28
  79. en:ivarimod -- r_associated #0: 28 / 0.651 -> en:autologous sarcoma cell lysate
    n1=en:ivarimod | n2=en:autologous sarcoma cell lysate | rel=r_associated | relid=0 | w=28
  80. en:ivarimod -- r_associated #0: 28 / 0.651 -> en:botanical extracts rinse izn-6n4
    n1=en:ivarimod | n2=en:botanical extracts rinse izn-6n4 | rel=r_associated | relid=0 | w=28
  81. en:ivarimod -- r_associated #0: 28 / 0.651 -> en:cd24 extracellular domain-igg1 fc domain recombinant fusion protein cd24fc
    n1=en:ivarimod | n2=en:cd24 extracellular domain-igg1 fc domain recombinant fusion protein cd24fc | rel=r_associated | relid=0 | w=28
  82. en:ivarimod -- r_associated #0: 28 / 0.651 -> en:cis-urocanic acid
    n1=en:ivarimod | n2=en:cis-urocanic acid | rel=r_associated | relid=0 | w=28
  83. en:ivarimod -- r_associated #0: 28 / 0.651 -> en:complement c5 inhibitor alxn1210
    n1=en:ivarimod | n2=en:complement c5 inhibitor alxn1210 | rel=r_associated | relid=0 | w=28
  84. en:ivarimod -- r_associated #0: 28 / 0.651 -> en:dersalazine
    n1=en:ivarimod | n2=en:dersalazine | rel=r_associated | relid=0 | w=28
  85. en:ivarimod -- r_associated #0: 28 / 0.651 -> en:east indian sandalwood oil mouth rinse
    n1=en:ivarimod | n2=en:east indian sandalwood oil mouth rinse | rel=r_associated | relid=0 | w=28
  86. en:ivarimod -- r_associated #0: 28 / 0.651 -> en:epetirimod esylate
    n1=en:ivarimod | n2=en:epetirimod esylate | rel=r_associated | relid=0 | w=28
  87. en:ivarimod -- r_associated #0: 28 / 0.651 -> en:etalocib
    n1=en:ivarimod | n2=en:etalocib | rel=r_associated | relid=0 | w=28
  88. en:ivarimod -- r_associated #0: 28 / 0.651 -> en:gitr agonist medi1873
    n1=en:ivarimod | n2=en:gitr agonist medi1873 | rel=r_associated | relid=0 | w=28
  89. en:ivarimod -- r_associated #0: 28 / 0.651 -> en:human thymosin-fraction 5
    n1=en:ivarimod | n2=en:human thymosin-fraction 5 | rel=r_associated | relid=0 | w=28
  90. en:ivarimod -- r_associated #0: 28 / 0.651 -> en:icrocaptide
    n1=en:ivarimod | n2=en:icrocaptide | rel=r_associated | relid=0 | w=28
  91. en:ivarimod -- r_associated #0: 28 / 0.651 -> en:isatoribine anhydrous
    n1=en:ivarimod | n2=en:isatoribine anhydrous | rel=r_associated | relid=0 | w=28
  92. en:ivarimod -- r_associated #0: 28 / 0.651 -> en:larazotide acetate
    n1=en:ivarimod | n2=en:larazotide acetate | rel=r_associated | relid=0 | w=28
  93. en:ivarimod -- r_associated #0: 28 / 0.651 -> en:therapeutic immune globulin
    n1=en:ivarimod | n2=en:therapeutic immune globulin | rel=r_associated | relid=0 | w=28
  94. en:ivarimod -- r_associated #0: 27 / 0.628 -> en:anitrazafen
    n1=en:ivarimod | n2=en:anitrazafen | rel=r_associated | relid=0 | w=27
  95. en:ivarimod -- r_associated #0: 27 / 0.628 -> en:antiserum
    n1=en:ivarimod | n2=en:antiserum | rel=r_associated | relid=0 | w=27
  96. en:ivarimod -- r_associated #0: 27 / 0.628 -> en:c3-targeted complement inhibitor apl-2
    n1=en:ivarimod | n2=en:c3-targeted complement inhibitor apl-2 | rel=r_associated | relid=0 | w=27
  97. en:ivarimod -- r_associated #0: 27 / 0.628 -> en:crl4(crbn) e3 ubiquitin ligase modulator cc-220
    n1=en:ivarimod | n2=en:crl4(crbn) e3 ubiquitin ligase modulator cc-220 | rel=r_associated | relid=0 | w=27
  98. en:ivarimod -- r_associated #0: 27 / 0.628 -> en:eritoran
    n1=en:ivarimod | n2=en:eritoran | rel=r_associated | relid=0 | w=27
  99. en:ivarimod -- r_associated #0: 27 / 0.628 -> en:golotimod
    n1=en:ivarimod | n2=en:golotimod | rel=r_associated | relid=0 | w=27
  100. en:ivarimod -- r_associated #0: 27 / 0.628 -> en:imexon
    n1=en:ivarimod | n2=en:imexon | rel=r_associated | relid=0 | w=27
  101. en:ivarimod -- r_associated #0: 27 / 0.628 -> en:laquinimod
    n1=en:ivarimod | n2=en:laquinimod | rel=r_associated | relid=0 | w=27
  102. en:ivarimod -- r_associated #0: 27 / 0.628 -> en:oglufanide
    n1=en:ivarimod | n2=en:oglufanide | rel=r_associated | relid=0 | w=27
  103. en:ivarimod -- r_associated #0: 27 / 0.628 -> en:procodazole
    n1=en:ivarimod | n2=en:procodazole | rel=r_associated | relid=0 | w=27
  104. en:ivarimod -- r_associated #0: 27 / 0.628 -> en:recombinant prothymosin alpha
    n1=en:ivarimod | n2=en:recombinant prothymosin alpha | rel=r_associated | relid=0 | w=27
  105. en:ivarimod -- r_associated #0: 27 / 0.628 -> en:remestemcel-l
    n1=en:ivarimod | n2=en:remestemcel-l | rel=r_associated | relid=0 | w=27
  106. en:ivarimod -- r_associated #0: 27 / 0.628 -> en:sotirimod
    n1=en:ivarimod | n2=en:sotirimod | rel=r_associated | relid=0 | w=27
  107. en:ivarimod -- r_associated #0: 26 / 0.605 -> en:alpha-1-proteinase inhibitor human
    n1=en:ivarimod | n2=en:alpha-1-proteinase inhibitor human | rel=r_associated | relid=0 | w=26
  108. en:ivarimod -- r_associated #0: 26 / 0.605 -> en:anti-tim-3 monoclonal antibody mbg453
    n1=en:ivarimod | n2=en:anti-tim-3 monoclonal antibody mbg453 | rel=r_associated | relid=0 | w=26
  109. en:ivarimod -- r_associated #0: 26 / 0.605 -> en:bispecific antibody
    n1=en:ivarimod | n2=en:bispecific antibody | rel=r_associated | relid=0 | w=26
  110. en:ivarimod -- r_associated #0: 26 / 0.605 -> en:bromelains
    n1=en:ivarimod | n2=en:bromelains | rel=r_associated | relid=0 | w=26
  111. en:ivarimod -- r_associated #0: 26 / 0.605 -> en:ciamexon
    n1=en:ivarimod | n2=en:ciamexon | rel=r_associated | relid=0 | w=26
  112. en:ivarimod -- r_associated #0: 26 / 0.605 -> en:eritoran tetrasodium
    n1=en:ivarimod | n2=en:eritoran tetrasodium | rel=r_associated | relid=0 | w=26
  113. en:ivarimod -- r_associated #0: 26 / 0.605 -> en:immunostimulant
    n1=en:ivarimod | n2=en:immunostimulant | rel=r_associated | relid=0 | w=26
  114. en:ivarimod -- r_associated #0: 26 / 0.605 -> en:nosantine
    n1=en:ivarimod | n2=en:nosantine | rel=r_associated | relid=0 | w=26
  115. en:ivarimod -- r_associated #0: 26 / 0.605 -> en:ovine submaxillary mucin
    n1=en:ivarimod | n2=en:ovine submaxillary mucin | rel=r_associated | relid=0 | w=26
  116. en:ivarimod -- r_associated #0: 26 / 0.605 -> en:xaliproden hydrochloride
    n1=en:ivarimod | n2=en:xaliproden hydrochloride | rel=r_associated | relid=0 | w=26
  117. en:ivarimod -- r_associated #0: 20 / 0.465 -> acétate de glatiramère
    n1=en:ivarimod | n2=acétate de glatiramère | rel=r_associated | relid=0 | w=20
  118. en:ivarimod -- r_associated #0: 20 / 0.465 -> adjuvant immunologique
    n1=en:ivarimod | n2=adjuvant immunologique | rel=r_associated | relid=0 | w=20
  119. en:ivarimod -- r_associated #0: 20 / 0.465 -> Adjuvant immunologique
    n1=en:ivarimod | n2=Adjuvant immunologique | rel=r_associated | relid=0 | w=20
  120. en:ivarimod -- r_associated #0: 20 / 0.465 -> en:adoptive cell therapy agent
    n1=en:ivarimod | n2=en:adoptive cell therapy agent | rel=r_associated | relid=0 | w=20
  121. en:ivarimod -- r_associated #0: 20 / 0.465 -> en:fda established names and unique ingredient identifier codes terminology
    n1=en:ivarimod | n2=en:fda established names and unique ingredient identifier codes terminology | rel=r_associated | relid=0 | w=20
  122. en:ivarimod -- r_associated #0: 20 / 0.465 -> en:moxilubant maleate
    n1=en:ivarimod | n2=en:moxilubant maleate | rel=r_associated | relid=0 | w=20
  123. en:ivarimod -- r_associated #0: 20 / 0.465 -> en:mycobacterium tuberculosis arabinomannan z-100
    n1=en:ivarimod | n2=en:mycobacterium tuberculosis arabinomannan z-100 | rel=r_associated | relid=0 | w=20
  124. en:ivarimod -- r_associated #0: 20 / 0.465 -> en:nsclc antigen-loaded dendritic cell-derived exosomes
    n1=en:ivarimod | n2=en:nsclc antigen-loaded dendritic cell-derived exosomes | rel=r_associated | relid=0 | w=20
  125. en:ivarimod -- r_associated #0: 20 / 0.465 -> en:orazipone
    n1=en:ivarimod | n2=en:orazipone | rel=r_associated | relid=0 | w=20
  126. en:ivarimod -- r_associated #0: 20 / 0.465 -> en:pd1 inhibitor
    n1=en:ivarimod | n2=en:pd1 inhibitor | rel=r_associated | relid=0 | w=20
  127. en:ivarimod -- r_associated #0: 20 / 0.465 -> en:preimplantation factor pif-1
    n1=en:ivarimod | n2=en:preimplantation factor pif-1 | rel=r_associated | relid=0 | w=20
  128. en:ivarimod -- r_associated #0: 20 / 0.465 -> en:pseudomonas aeruginosa preparation
    n1=en:ivarimod | n2=en:pseudomonas aeruginosa preparation | rel=r_associated | relid=0 | w=20
  129. en:ivarimod -- r_associated #0: 20 / 0.465 -> en:recombinant mip1-alpha variant eci301
    n1=en:ivarimod | n2=en:recombinant mip1-alpha variant eci301 | rel=r_associated | relid=0 | w=20
  130. en:ivarimod -- r_associated #0: 20 / 0.465 -> en:recombinant thymosin
    n1=en:ivarimod | n2=en:recombinant thymosin | rel=r_associated | relid=0 | w=20
  131. en:ivarimod -- r_associated #0: 20 / 0.465 -> en:rig-i selective ligand rgt100
    n1=en:ivarimod | n2=en:rig-i selective ligand rgt100 | rel=r_associated | relid=0 | w=20
  132. en:ivarimod -- r_associated #0: 20 / 0.465 -> en:rimiducid
    n1=en:ivarimod | n2=en:rimiducid | rel=r_associated | relid=0 | w=20
  133. en:ivarimod -- r_associated #0: 20 / 0.465 -> en:sitogluside
    n1=en:ivarimod | n2=en:sitogluside | rel=r_associated | relid=0 | w=20
  134. en:ivarimod -- r_associated #0: 20 / 0.465 -> en:tasquinimod
    n1=en:ivarimod | n2=en:tasquinimod | rel=r_associated | relid=0 | w=20
  135. en:ivarimod -- r_associated #0: 20 / 0.465 -> en:thymalfasin
    n1=en:ivarimod | n2=en:thymalfasin | rel=r_associated | relid=0 | w=20
  136. en:ivarimod -- r_associated #0: 20 / 0.465 -> immunostimulant
    n1=en:ivarimod | n2=immunostimulant | rel=r_associated | relid=0 | w=20
  137. en:ivarimod -- r_associated #0: 20 / 0.465 -> ponesimod
    n1=en:ivarimod | n2=ponesimod | rel=r_associated | relid=0 | w=20
≈ 143 relations entrantes

  1. ponesimod --- r_associated #0: 72 --> en:ivarimod
    n1=ponesimod | n2=en:ivarimod | rel=r_associated | relid=0 | w=72
  2. en:ponesimod --- r_associated #0: 68 --> en:ivarimod
    n1=en:ponesimod | n2=en:ivarimod | rel=r_associated | relid=0 | w=68
  3. en:immunostimulant --- r_associated #0: 66 --> en:ivarimod
    n1=en:immunostimulant | n2=en:ivarimod | rel=r_associated | relid=0 | w=66
  4. immunostimulant --- r_associated #0: 62 --> en:ivarimod
    n1=immunostimulant | n2=en:ivarimod | rel=r_associated | relid=0 | w=62
  5. adjuvant immunologique --- r_associated #0: 51 --> en:ivarimod
    n1=adjuvant immunologique | n2=en:ivarimod | rel=r_associated | relid=0 | w=51
  6. en:immunoadjuvant --- r_associated #0: 47 --> en:ivarimod
    n1=en:immunoadjuvant | n2=en:ivarimod | rel=r_associated | relid=0 | w=47
  7. Adjuvant immunologique --- r_associated #0: 45 --> en:ivarimod
    n1=Adjuvant immunologique | n2=en:ivarimod | rel=r_associated | relid=0 | w=45
  8. en:adoptive cell therapy agent --- r_associated #0: 43 --> en:ivarimod
    n1=en:adoptive cell therapy agent | n2=en:ivarimod | rel=r_associated | relid=0 | w=43
  9. en:apilimod --- r_associated #0: 42 --> en:ivarimod
    n1=en:apilimod | n2=en:ivarimod | rel=r_associated | relid=0 | w=42
  10. en:dersalazine --- r_associated #0: 42 --> en:ivarimod
    n1=en:dersalazine | n2=en:ivarimod | rel=r_associated | relid=0 | w=42
  11. acétate de glatiramère --- r_associated #0: 40 --> en:ivarimod
    n1=acétate de glatiramère | n2=en:ivarimod | rel=r_associated | relid=0 | w=40
  12. en:2-o, 3-o desulfated heparin --- r_associated #0: 40 --> en:ivarimod
    n1=en:2-o, 3-o desulfated heparin | n2=en:ivarimod | rel=r_associated | relid=0 | w=40
  13. en:clonidine-containing mucoadhesive buccal tablet --- r_associated #0: 40 --> en:ivarimod
    n1=en:clonidine-containing mucoadhesive buccal tablet | n2=en:ivarimod | rel=r_associated | relid=0 | w=40
  14. en:icrocaptide --- r_associated #0: 40 --> en:ivarimod
    n1=en:icrocaptide | n2=en:ivarimod | rel=r_associated | relid=0 | w=40
  15. en:oglufanide --- r_associated #0: 40 --> en:ivarimod
    n1=en:oglufanide | n2=en:ivarimod | rel=r_associated | relid=0 | w=40
  16. en:pimelautide --- r_associated #0: 39 --> en:ivarimod
    n1=en:pimelautide | n2=en:ivarimod | rel=r_associated | relid=0 | w=39
  17. en:rimiducid --- r_associated #0: 39 --> en:ivarimod
    n1=en:rimiducid | n2=en:ivarimod | rel=r_associated | relid=0 | w=39
  18. en:preimplantation factor pif-1 --- r_associated #0: 37 --> en:ivarimod
    n1=en:preimplantation factor pif-1 | n2=en:ivarimod | rel=r_associated | relid=0 | w=37
  19. en:anti-tim-3 monoclonal antibody mbg453 --- r_associated #0: 36 --> en:ivarimod
    n1=en:anti-tim-3 monoclonal antibody mbg453 | n2=en:ivarimod | rel=r_associated | relid=0 | w=36
  20. en:glatiramer acetate --- r_associated #0: 36 --> en:ivarimod
    n1=en:glatiramer acetate | n2=en:ivarimod | rel=r_associated | relid=0 | w=36
  21. en:bromelains --- r_associated #0: 35 --> en:ivarimod
    n1=en:bromelains | n2=en:ivarimod | rel=r_associated | relid=0 | w=35
  22. en:cridanimod --- r_associated #0: 35 --> en:ivarimod
    n1=en:cridanimod | n2=en:ivarimod | rel=r_associated | relid=0 | w=35
  23. en:eritoran tetrasodium --- r_associated #0: 35 --> en:ivarimod
    n1=en:eritoran tetrasodium | n2=en:ivarimod | rel=r_associated | relid=0 | w=35
  24. en:glatiramer --- r_associated #0: 35 --> en:ivarimod
    n1=en:glatiramer | n2=en:ivarimod | rel=r_associated | relid=0 | w=35
  25. en:monoacetyldiglyceride ec-18 --- r_associated #0: 35 --> en:ivarimod
    n1=en:monoacetyldiglyceride ec-18 | n2=en:ivarimod | rel=r_associated | relid=0 | w=35
  26. en:nsclc antigen-loaded dendritic cell-derived exosomes --- r_associated #0: 35 --> en:ivarimod
    n1=en:nsclc antigen-loaded dendritic cell-derived exosomes | n2=en:ivarimod | rel=r_associated | relid=0 | w=35
  27. en:recombinant cytokine --- r_associated #0: 35 --> en:ivarimod
    n1=en:recombinant cytokine | n2=en:ivarimod | rel=r_associated | relid=0 | w=35
  28. en:recombinant mip1-alpha variant eci301 --- r_associated #0: 35 --> en:ivarimod
    n1=en:recombinant mip1-alpha variant eci301 | n2=en:ivarimod | rel=r_associated | relid=0 | w=35
  29. en:recombinant prothymosin alpha --- r_associated #0: 35 --> en:ivarimod
    n1=en:recombinant prothymosin alpha | n2=en:ivarimod | rel=r_associated | relid=0 | w=35
  30. en:allodepleted haploidentical t cells-expressing inducible caspase 9 --- r_associated #0: 34 --> en:ivarimod
    n1=en:allodepleted haploidentical t cells-expressing inducible caspase 9 | n2=en:ivarimod | rel=r_associated | relid=0 | w=34
  31. en:complement c5 inhibitor alxn1210 --- r_associated #0: 34 --> en:ivarimod
    n1=en:complement c5 inhibitor alxn1210 | n2=en:ivarimod | rel=r_associated | relid=0 | w=34
  32. en:golotimod --- r_associated #0: 34 --> en:ivarimod
    n1=en:golotimod | n2=en:ivarimod | rel=r_associated | relid=0 | w=34
  33. en:immunomodulator ohr/avr118 --- r_associated #0: 34 --> en:ivarimod
    n1=en:immunomodulator ohr/avr118 | n2=en:ivarimod | rel=r_associated | relid=0 | w=34
  34. en:isatoribine anhydrous --- r_associated #0: 34 --> en:ivarimod
    n1=en:isatoribine anhydrous | n2=en:ivarimod | rel=r_associated | relid=0 | w=34
  35. en:multifunctional/multitargeted anticancer agent omn54 --- r_associated #0: 34 --> en:ivarimod
    n1=en:multifunctional/multitargeted anticancer agent omn54 | n2=en:ivarimod | rel=r_associated | relid=0 | w=34
  36. en:thymalfasin --- r_associated #0: 34 --> en:ivarimod
    n1=en:thymalfasin | n2=en:ivarimod | rel=r_associated | relid=0 | w=34
  37. en:anti-cd20 monoclonal antibody-interferon-alpha fusion protein ign002 --- r_associated #0: 32 --> en:ivarimod
    n1=en:anti-cd20 monoclonal antibody-interferon-alpha fusion protein ign002 | n2=en:ivarimod | rel=r_associated | relid=0 | w=32
  38. en:boswellia serrata extract --- r_associated #0: 32 --> en:ivarimod
    n1=en:boswellia serrata extract | n2=en:ivarimod | rel=r_associated | relid=0 | w=32
  39. en:epetirimod esylate --- r_associated #0: 32 --> en:ivarimod
    n1=en:epetirimod esylate | n2=en:ivarimod | rel=r_associated | relid=0 | w=32
  40. en:iguratimod --- r_associated #0: 32 --> en:ivarimod
    n1=en:iguratimod | n2=en:ivarimod | rel=r_associated | relid=0 | w=32
  41. en:laquinimod --- r_associated #0: 32 --> en:ivarimod
    n1=en:laquinimod | n2=en:ivarimod | rel=r_associated | relid=0 | w=32
  42. en:poly-gamma glutamic acid --- r_associated #0: 32 --> en:ivarimod
    n1=en:poly-gamma glutamic acid | n2=en:ivarimod | rel=r_associated | relid=0 | w=32
  43. en:pseudomonas aeruginosa preparation --- r_associated #0: 32 --> en:ivarimod
    n1=en:pseudomonas aeruginosa preparation | n2=en:ivarimod | rel=r_associated | relid=0 | w=32
  44. en:sheng-yu-tang --- r_associated #0: 32 --> en:ivarimod
    n1=en:sheng-yu-tang | n2=en:ivarimod | rel=r_associated | relid=0 | w=32
  45. en:anti-pd-l1/tgfbetarii fusion protein msb0011359c --- r_associated #0: 31 --> en:ivarimod
    n1=en:anti-pd-l1/tgfbetarii fusion protein msb0011359c | n2=en:ivarimod | rel=r_associated | relid=0 | w=31
  46. en:autologous glioma cell lysate --- r_associated #0: 31 --> en:ivarimod
    n1=en:autologous glioma cell lysate | n2=en:ivarimod | rel=r_associated | relid=0 | w=31
  47. en:high-selenium baker's yeast --- r_associated #0: 31 --> en:ivarimod
    n1=en:high-selenium baker's yeast | n2=en:ivarimod | rel=r_associated | relid=0 | w=31
  48. en:hpv16 l2/e6/e7 fusion protein vaccine ta-cin --- r_associated #0: 31 --> en:ivarimod
    n1=en:hpv16 l2/e6/e7 fusion protein vaccine ta-cin | n2=en:ivarimod | rel=r_associated | relid=0 | w=31
  49. en:nitroglycerin transdermal patch --- r_associated #0: 31 --> en:ivarimod
    n1=en:nitroglycerin transdermal patch | n2=en:ivarimod | rel=r_associated | relid=0 | w=31
  50. en:sitogluside --- r_associated #0: 31 --> en:ivarimod
    n1=en:sitogluside | n2=en:ivarimod | rel=r_associated | relid=0 | w=31
  51. en:anti-il-4/il-13 combination agent qbx258 --- r_associated #0: 30 --> en:ivarimod
    n1=en:anti-il-4/il-13 combination agent qbx258 | n2=en:ivarimod | rel=r_associated | relid=0 | w=30
  52. en:cathelicidin ll-37 --- r_associated #0: 30 --> en:ivarimod
    n1=en:cathelicidin ll-37 | n2=en:ivarimod | rel=r_associated | relid=0 | w=30
  53. en:cd24 extracellular domain-igg1 fc domain recombinant fusion protein cd24fc --- r_associated #0: 30 --> en:ivarimod
    n1=en:cd24 extracellular domain-igg1 fc domain recombinant fusion protein cd24fc | n2=en:ivarimod | rel=r_associated | relid=0 | w=30
  54. en:ciamexon --- r_associated #0: 30 --> en:ivarimod
    n1=en:ciamexon | n2=en:ivarimod | rel=r_associated | relid=0 | w=30
  55. en:fucosylated umbilical cord blood regulatory t cells --- r_associated #0: 30 --> en:ivarimod
    n1=en:fucosylated umbilical cord blood regulatory t cells | n2=en:ivarimod | rel=r_associated | relid=0 | w=30
  56. en:larazotide --- r_associated #0: 30 --> en:ivarimod
    n1=en:larazotide | n2=en:ivarimod | rel=r_associated | relid=0 | w=30
  57. en:nosantine --- r_associated #0: 30 --> en:ivarimod
    n1=en:nosantine | n2=en:ivarimod | rel=r_associated | relid=0 | w=30
  58. en:pd1 inhibitor --- r_associated #0: 30 --> en:ivarimod
    n1=en:pd1 inhibitor | n2=en:ivarimod | rel=r_associated | relid=0 | w=30
  59. en:recombinant thymosin --- r_associated #0: 30 --> en:ivarimod
    n1=en:recombinant thymosin | n2=en:ivarimod | rel=r_associated | relid=0 | w=30
  60. en:rig-i selective ligand rgt100 --- r_associated #0: 30 --> en:ivarimod
    n1=en:rig-i selective ligand rgt100 | n2=en:ivarimod | rel=r_associated | relid=0 | w=30
  61. en:cis-urocanic acid --- r_associated #0: 29 --> en:ivarimod
    n1=en:cis-urocanic acid | n2=en:ivarimod | rel=r_associated | relid=0 | w=29
  62. en:edratide --- r_associated #0: 29 --> en:ivarimod
    n1=en:edratide | n2=en:ivarimod | rel=r_associated | relid=0 | w=29
  63. en:esonarimod --- r_associated #0: 29 --> en:ivarimod
    n1=en:esonarimod | n2=en:ivarimod | rel=r_associated | relid=0 | w=29
  64. en:il-10 immunomodulator mk-1966 --- r_associated #0: 29 --> en:ivarimod
    n1=en:il-10 immunomodulator mk-1966 | n2=en:ivarimod | rel=r_associated | relid=0 | w=29
  65. en:immunotherapy regimen mkc-1106-mt --- r_associated #0: 29 --> en:ivarimod
    n1=en:immunotherapy regimen mkc-1106-mt | n2=en:ivarimod | rel=r_associated | relid=0 | w=29
  66. en:omtriptolide sodium --- r_associated #0: 29 --> en:ivarimod
    n1=en:omtriptolide sodium | n2=en:ivarimod | rel=r_associated | relid=0 | w=29
  67. en:orazipone --- r_associated #0: 29 --> en:ivarimod
    n1=en:orazipone | n2=en:ivarimod | rel=r_associated | relid=0 | w=29
  68. en:tasquinimod --- r_associated #0: 29 --> en:ivarimod
    n1=en:tasquinimod | n2=en:ivarimod | rel=r_associated | relid=0 | w=29
  69. en:alpha-1-proteinase inhibitor human --- r_associated #0: 28 --> en:ivarimod
    n1=en:alpha-1-proteinase inhibitor human | n2=en:ivarimod | rel=r_associated | relid=0 | w=28
  70. en:amnion-derived cellular cytokine solution --- r_associated #0: 28 --> en:ivarimod
    n1=en:amnion-derived cellular cytokine solution | n2=en:ivarimod | rel=r_associated | relid=0 | w=28
  71. en:atiprimod --- r_associated #0: 28 --> en:ivarimod
    n1=en:atiprimod | n2=en:ivarimod | rel=r_associated | relid=0 | w=28
  72. en:brilacidin oral rinse --- r_associated #0: 28 --> en:ivarimod
    n1=en:brilacidin oral rinse | n2=en:ivarimod | rel=r_associated | relid=0 | w=28
  73. en:fingolimod hydrochloride --- r_associated #0: 28 --> en:ivarimod
    n1=en:fingolimod hydrochloride | n2=en:ivarimod | rel=r_associated | relid=0 | w=28
  74. en:histamine-1 receptor antagonist --- r_associated #0: 28 --> en:ivarimod
    n1=en:histamine-1 receptor antagonist | n2=en:ivarimod | rel=r_associated | relid=0 | w=28
  75. en:imexon --- r_associated #0: 28 --> en:ivarimod
    n1=en:imexon | n2=en:ivarimod | rel=r_associated | relid=0 | w=28
  76. en:moxilubant maleate --- r_associated #0: 28 --> en:ivarimod
    n1=en:moxilubant maleate | n2=en:ivarimod | rel=r_associated | relid=0 | w=28
  77. en:pd-l1/pd-l2/vista antagonist ca-170 --- r_associated #0: 28 --> en:ivarimod
    n1=en:pd-l1/pd-l2/vista antagonist ca-170 | n2=en:ivarimod | rel=r_associated | relid=0 | w=28
  78. en:sotirimod --- r_associated #0: 28 --> en:ivarimod
    n1=en:sotirimod | n2=en:ivarimod | rel=r_associated | relid=0 | w=28
  79. en:anti-pd-1 fusion protein amp-224 --- r_associated #0: 27 --> en:ivarimod
    n1=en:anti-pd-1 fusion protein amp-224 | n2=en:ivarimod | rel=r_associated | relid=0 | w=27
  80. en:chemokine receptor antagonist --- r_associated #0: 27 --> en:ivarimod
    n1=en:chemokine receptor antagonist | n2=en:ivarimod | rel=r_associated | relid=0 | w=27
  81. en:larazotide acetate --- r_associated #0: 27 --> en:ivarimod
    n1=en:larazotide acetate | n2=en:ivarimod | rel=r_associated | relid=0 | w=27
  82. en:tabilautide --- r_associated #0: 27 --> en:ivarimod
    n1=en:tabilautide | n2=en:ivarimod | rel=r_associated | relid=0 | w=27
  83. en:allogeneic cd56-positive cd3-negative natural killer cells --- r_associated #0: 26 --> en:ivarimod
    n1=en:allogeneic cd56-positive cd3-negative natural killer cells | n2=en:ivarimod | rel=r_associated | relid=0 | w=26
  84. en:apilimod dimesylate capsule --- r_associated #0: 26 --> en:ivarimod
    n1=en:apilimod dimesylate capsule | n2=en:ivarimod | rel=r_associated | relid=0 | w=26
  85. en:atiprimod dihydrochloride --- r_associated #0: 26 --> en:ivarimod
    n1=en:atiprimod dihydrochloride | n2=en:ivarimod | rel=r_associated | relid=0 | w=26
  86. en:atiprimod dimaleate --- r_associated #0: 26 --> en:ivarimod
    n1=en:atiprimod dimaleate | n2=en:ivarimod | rel=r_associated | relid=0 | w=26
  87. en:bispecific antibody --- r_associated #0: 26 --> en:ivarimod
    n1=en:bispecific antibody | n2=en:ivarimod | rel=r_associated | relid=0 | w=26
  88. en:crl4(crbn) e3 ubiquitin ligase modulator cc-220 --- r_associated #0: 26 --> en:ivarimod
    n1=en:crl4(crbn) e3 ubiquitin ligase modulator cc-220 | n2=en:ivarimod | rel=r_associated | relid=0 | w=26
  89. en:east indian sandalwood oil mouth rinse --- r_associated #0: 26 --> en:ivarimod
    n1=en:east indian sandalwood oil mouth rinse | n2=en:ivarimod | rel=r_associated | relid=0 | w=26
  90. en:fda established names and unique ingredient identifier codes terminology --- r_associated #0: 26 --> en:ivarimod
    n1=en:fda established names and unique ingredient identifier codes terminology | n2=en:ivarimod | rel=r_associated | relid=0 | w=26
  91. en:mycobacterium tuberculosis arabinomannan z-100 --- r_associated #0: 26 --> en:ivarimod
    n1=en:mycobacterium tuberculosis arabinomannan z-100 | n2=en:ivarimod | rel=r_associated | relid=0 | w=26
  92. en:remestemcel-l --- r_associated #0: 26 --> en:ivarimod
    n1=en:remestemcel-l | n2=en:ivarimod | rel=r_associated | relid=0 | w=26
  93. en:714-x --- r_associated #0: 20 --> en:ivarimod
    n1=en:714-x | n2=en:ivarimod | rel=r_associated | relid=0 | w=20
  94. en:adalimumab --- r_associated #0: 20 --> en:ivarimod
    n1=en:adalimumab | n2=en:ivarimod | rel=r_associated | relid=0 | w=20
  95. en:agaricus blazei murill extract --- r_associated #0: 20 --> en:ivarimod
    n1=en:agaricus blazei murill extract | n2=en:ivarimod | rel=r_associated | relid=0 | w=20
  96. en:almurtide --- r_associated #0: 20 --> en:ivarimod
    n1=en:almurtide | n2=en:ivarimod | rel=r_associated | relid=0 | w=20
  97. en:anitrazafen --- r_associated #0: 20 --> en:ivarimod
    n1=en:anitrazafen | n2=en:ivarimod | rel=r_associated | relid=0 | w=20
  98. en:anti-cd40l fc-fusion protein bms-986004 --- r_associated #0: 20 --> en:ivarimod
    n1=en:anti-cd40l fc-fusion protein bms-986004 | n2=en:ivarimod | rel=r_associated | relid=0 | w=20
  99. en:anti-pd-1 checkpoint inhibitor pf-06801591 --- r_associated #0: 20 --> en:ivarimod
    n1=en:anti-pd-1 checkpoint inhibitor pf-06801591 | n2=en:ivarimod | rel=r_associated | relid=0 | w=20
  100. en:antiserum --- r_associated #0: 20 --> en:ivarimod
    n1=en:antiserum | n2=en:ivarimod | rel=r_associated | relid=0 | w=20
  101. en:apilimod mesylate --- r_associated #0: 20 --> en:ivarimod
    n1=en:apilimod mesylate | n2=en:ivarimod | rel=r_associated | relid=0 | w=20
  102. en:autologous sarcoma cell lysate --- r_associated #0: 20 --> en:ivarimod
    n1=en:autologous sarcoma cell lysate | n2=en:ivarimod | rel=r_associated | relid=0 | w=20
  103. en:botanical extracts rinse izn-6n4 --- r_associated #0: 20 --> en:ivarimod
    n1=en:botanical extracts rinse izn-6n4 | n2=en:ivarimod | rel=r_associated | relid=0 | w=20
  104. en:c3-targeted complement inhibitor apl-2 --- r_associated #0: 20 --> en:ivarimod
    n1=en:c3-targeted complement inhibitor apl-2 | n2=en:ivarimod | rel=r_associated | relid=0 | w=20
  105. en:chining decoction --- r_associated #0: 20 --> en:ivarimod
    n1=en:chining decoction | n2=en:ivarimod | rel=r_associated | relid=0 | w=20
  106. en:cndo-109-activated allogeneic natural killer cells --- r_associated #0: 20 --> en:ivarimod
    n1=en:cndo-109-activated allogeneic natural killer cells | n2=en:ivarimod | rel=r_associated | relid=0 | w=20
  107. en:dimepranol acedoben --- r_associated #0: 20 --> en:ivarimod
    n1=en:dimepranol acedoben | n2=en:ivarimod | rel=r_associated | relid=0 | w=20
  108. en:epetirimod --- r_associated #0: 20 --> en:ivarimod
    n1=en:epetirimod | n2=en:ivarimod | rel=r_associated | relid=0 | w=20
  109. en:eritoran --- r_associated #0: 20 --> en:ivarimod
    n1=en:eritoran | n2=en:ivarimod | rel=r_associated | relid=0 | w=20
  110. en:etalocib --- r_associated #0: 20 --> en:ivarimod
    n1=en:etalocib | n2=en:ivarimod | rel=r_associated | relid=0 | w=20
  111. en:fingolimod --- r_associated #0: 20 --> en:ivarimod
    n1=en:fingolimod | n2=en:ivarimod | rel=r_associated | relid=0 | w=20
  112. en:french maritime pine bark extract --- r_associated #0: 20 --> en:ivarimod
    n1=en:french maritime pine bark extract | n2=en:ivarimod | rel=r_associated | relid=0 | w=20
  113. en:gitr agonist medi1873 --- r_associated #0: 20 --> en:ivarimod
    n1=en:gitr agonist medi1873 | n2=en:ivarimod | rel=r_associated | relid=0 | w=20
  114. en:h1299 tumor cell lysate vaccine --- r_associated #0: 20 --> en:ivarimod
    n1=en:h1299 tumor cell lysate vaccine | n2=en:ivarimod | rel=r_associated | relid=0 | w=20
  115. en:heterodimeric interleukin-15 --- r_associated #0: 20 --> en:ivarimod
    n1=en:heterodimeric interleukin-15 | n2=en:ivarimod | rel=r_associated | relid=0 | w=20
  116. en:highly purified staphylococcal protein a prtx-100 --- r_associated #0: 20 --> en:ivarimod
    n1=en:highly purified staphylococcal protein a prtx-100 | n2=en:ivarimod | rel=r_associated | relid=0 | w=20
  117. en:human thymosin-fraction 5 --- r_associated #0: 20 --> en:ivarimod
    n1=en:human thymosin-fraction 5 | n2=en:ivarimod | rel=r_associated | relid=0 | w=20
  118. en:hyperimmune bovine colostrum --- r_associated #0: 20 --> en:ivarimod
    n1=en:hyperimmune bovine colostrum | n2=en:ivarimod | rel=r_associated | relid=0 | w=20
  119. en:imiquimod --- r_associated #0: 20 --> en:ivarimod
    n1=en:imiquimod | n2=en:ivarimod | rel=r_associated | relid=0 | w=20
  120. en:immunoconjugate --- r_associated #0: 20 --> en:ivarimod
    n1=en:immunoconjugate | n2=en:ivarimod | rel=r_associated | relid=0 | w=20
  121. en:immunosuppressant --- r_associated #0: 20 --> en:ivarimod
    n1=en:immunosuppressant | n2=en:ivarimod | rel=r_associated | relid=0 | w=20
  122. en:injectable astragalus membranaceus polysaccharide --- r_associated #0: 20 --> en:ivarimod
    n1=en:injectable astragalus membranaceus polysaccharide | n2=en:ivarimod | rel=r_associated | relid=0 | w=20
  123. en:isatoribine --- r_associated #0: 20 --> en:ivarimod
    n1=en:isatoribine | n2=en:ivarimod | rel=r_associated | relid=0 | w=20
  124. en:lactobacillus brevis cd2 lozenge --- r_associated #0: 20 --> en:ivarimod
    n1=en:lactobacillus brevis cd2 lozenge | n2=en:ivarimod | rel=r_associated | relid=0 | w=20
  125. en:laquinimod sodium --- r_associated #0: 20 --> en:ivarimod
    n1=en:laquinimod sodium | n2=en:ivarimod | rel=r_associated | relid=0 | w=20
  126. en:lenalidomide --- r_associated #0: 20 --> en:ivarimod
    n1=en:lenalidomide | n2=en:ivarimod | rel=r_associated | relid=0 | w=20
  127. en:mannose-binding lectin --- r_associated #0: 20 --> en:ivarimod
    n1=en:mannose-binding lectin | n2=en:ivarimod | rel=r_associated | relid=0 | w=20
  128. en:microparticle mdp/bacterial dna-containing mis416 --- r_associated #0: 20 --> en:ivarimod
    n1=en:microparticle mdp/bacterial dna-containing mis416 | n2=en:ivarimod | rel=r_associated | relid=0 | w=20
  129. en:ovine submaxillary mucin --- r_associated #0: 20 --> en:ivarimod
    n1=en:ovine submaxillary mucin | n2=en:ivarimod | rel=r_associated | relid=0 | w=20
  130. en:procodazole --- r_associated #0: 20 --> en:ivarimod
    n1=en:procodazole | n2=en:ivarimod | rel=r_associated | relid=0 | w=20
  131. en:resiquimod --- r_associated #0: 20 --> en:ivarimod
    n1=en:resiquimod | n2=en:ivarimod | rel=r_associated | relid=0 | w=20
  132. en:rilonacept --- r_associated #0: 20 --> en:ivarimod
    n1=en:rilonacept | n2=en:ivarimod | rel=r_associated | relid=0 | w=20
  133. en:superagonist interleukin-15:interleukin-15 receptor alphasu/fc fusion complex alt-803 --- r_associated #0: 20 --> en:ivarimod
    n1=en:superagonist interleukin-15:interleukin-15 receptor alphasu/fc fusion complex alt-803 | n2=en:ivarimod | rel=r_associated | relid=0 | w=20
  134. en:therapeutic immune globulin --- r_associated #0: 20 --> en:ivarimod
    n1=en:therapeutic immune globulin | n2=en:ivarimod | rel=r_associated | relid=0 | w=20
  135. en:ticolubant --- r_associated #0: 20 --> en:ivarimod
    n1=en:ticolubant | n2=en:ivarimod | rel=r_associated | relid=0 | w=20
  136. en:umbilical cord blood-derived natural killer cells --- r_associated #0: 20 --> en:ivarimod
    n1=en:umbilical cord blood-derived natural killer cells | n2=en:ivarimod | rel=r_associated | relid=0 | w=20
  137. en:xaliproden hydrochloride --- r_associated #0: 20 --> en:ivarimod
    n1=en:xaliproden hydrochloride | n2=en:ivarimod | rel=r_associated | relid=0 | w=20
  138. Immunostimulant --- r_associated #0: 15 --> en:ivarimod
    n1=Immunostimulant | n2=en:ivarimod | rel=r_associated | relid=0 | w=15
  139. adalimumab --- r_associated #0: 10 --> en:ivarimod
    n1=adalimumab | n2=en:ivarimod | rel=r_associated | relid=0 | w=10
  140. imiquimod --- r_associated #0: 10 --> en:ivarimod
    n1=imiquimod | n2=en:ivarimod | rel=r_associated | relid=0 | w=10
  141. immunoperoxydases en dermatologie (technique des) --- r_associated #0: 10 --> en:ivarimod
    n1=immunoperoxydases en dermatologie (technique des) | n2=en:ivarimod | rel=r_associated | relid=0 | w=10
  142. immunosuppresseur --- r_associated #0: 10 --> en:ivarimod
    n1=immunosuppresseur | n2=en:ivarimod | rel=r_associated | relid=0 | w=10
  143. rilonacept --- r_associated #0: 10 --> en:ivarimod
    n1=rilonacept | n2=en:ivarimod | rel=r_associated | relid=0 | w=10
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr